Fleischhacker WW - Search Results

1

Switching between second-generation antipsychotics: why and how?

Edlinger M, Baumgartner S, Eltanaihi-Furtmüller N, Hummer M, Fleischhacker WW. Edlinger M, et al. Among authors: fleischhacker ww. CNS Drugs. 2005;19(1):27-42. doi: 10.2165/00023210-200519010-00003. CNS Drugs. 2005. PMID: 15651903 Review.

2

Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia.

Hofer A, Kemmler G, Eder U, Honeder M, Hummer M, Fleischhacker WW. Hofer A, et al. Among authors: fleischhacker ww. J Clin Psychiatry. 2002 Jan;63(1):49-53. doi: 10.4088/jcp.v63n0110. J Clin Psychiatry. 2002. PMID: 11838626

3

The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.

Weiss EM, Bilder RM, Fleischhacker WW. Weiss EM, et al. Among authors: fleischhacker ww. Psychopharmacology (Berl). 2002 Jun;162(1):11-7. doi: 10.1007/s00213-002-1053-y. Epub 2002 Apr 17. Psychopharmacology (Berl). 2002. PMID: 12107611 Review.

4

Attitudes of patients with schizophrenia toward placebo-controlled clinical trials.

Hummer M, Holzmeister R, Kemmler G, Eder U, Hofer A, Kurzthaler I, Oehl M, Weiss E, Fleischhacker WW. Hummer M, et al. Among authors: fleischhacker ww. J Clin Psychiatry. 2003 Mar;64(3):277-81. doi: 10.4088/jcp.v64n0308. J Clin Psychiatry. 2003. PMID: 12716268

5

Brain activation patterns during a selective attention test-a functional MRI study in healthy volunteers and patients with schizophrenia.

Weiss EM, Golaszewski S, Mottaghy FM, Hofer A, Hausmann A, Kemmler G, Kremser C, Brinkhoff C, Felber SR, Fleischhacker WW. Weiss EM, et al. Among authors: fleischhacker ww. Psychiatry Res. 2003 May 1;123(1):1-15. doi: 10.1016/s0925-4927(03)00019-2. Psychiatry Res. 2003. PMID: 12738340

6

Placebo or active control trials of antipsychotic drugs?

Fleischhacker WW, Czobor P, Hummer M, Kemmler G, Kohnen R, Volavka J. Fleischhacker WW, et al. Arch Gen Psychiatry. 2003 May;60(5):458-64. doi: 10.1001/archpsyc.60.5.458. Arch Gen Psychiatry. 2003. PMID: 12742866 Review.

7

The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia.

Hofer A, Hummer M, Kemmler G, Kurz M, Kurzthaler I, Fleischhacker WW. Hofer A, et al. Among authors: fleischhacker ww. Int J Neuropsychopharmacol. 2003 Sep;6(3):201-6. doi: 10.1017/S1461145703003456. Int J Neuropsychopharmacol. 2003. PMID: 12974985 Free article.

8

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.

Fleischhacker WW, Eerdekens M, Karcher K, Remington G, Llorca PM, Chrzanowski W, Martin S, Gefvert O. Fleischhacker WW, et al. J Clin Psychiatry. 2003 Oct;64(10):1250-7. doi: 10.4088/jcp.v64n1017. J Clin Psychiatry. 2003. PMID: 14658976 Clinical Trial.

9

Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient.

Hofer A, Fleischhacker WW, Hummer M. Hofer A, et al. Among authors: fleischhacker ww. J Clin Psychiatry. 2003 Oct;64(10):1267-8. doi: 10.4088/jcp.v64n1019c. J Clin Psychiatry. 2003. PMID: 14658980 No abstract available.

10

Factors influencing compliance in schizophrenia patients.

Fleischhacker WW, Oehl MA, Hummer M. Fleischhacker WW, et al. J Clin Psychiatry. 2003;64 Suppl 16:10-3. J Clin Psychiatry. 2003. PMID: 14680413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters